A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Abbott Laboratories stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 229,925 shares of ABT stock, worth $29.4 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
229,925
Previous 352,827 34.83%
Holding current value
$29.4 Million
Previous $36.7 Million 28.5%
% of portfolio
0.14%
Previous 0.21%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$100.07 - $118.13 $12.3 Million - $14.5 Million
-122,902 Reduced 34.83%
229,925 $26.2 Million
Q2 2024

Aug 14, 2024

SELL
$100.73 - $112.44 $4.56 Million - $5.09 Million
-45,230 Reduced 11.36%
352,827 $36.7 Million
Q1 2024

May 15, 2024

BUY
$109.52 - $120.96 $43.6 Million - $48.1 Million
398,057 New
398,057 $44.8 Billion
Q4 2023

Aug 14, 2024

SELL
$90.19 - $110.4 $2.25 Million - $2.76 Million
-24,996 Reduced 7.73%
298,259 $32.8 Billion
Q3 2023

Aug 14, 2024

SELL
$95.53 - $114.62 $426,828 - $512,122
-4,468 Reduced 1.36%
323,255 $31.3 Billion
Q2 2023

Aug 14, 2024

BUY
$100.78 - $112.29 $2.89 Million - $3.22 Million
28,659 Added 9.58%
327,723 $35.7 Billion
Q1 2023

Aug 14, 2024

BUY
$96.86 - $114.01 $18.5 Million - $21.8 Million
191,004 Added 176.76%
299,064 $30.3 Billion
Q4 2022

Aug 14, 2024

SELL
$95.06 - $111.52 $15.8 Million - $18.5 Million
-166,274 Reduced 60.61%
108,060 $11.9 Billion
Q3 2022

Aug 14, 2024

BUY
$96.76 - $112.03 $2.59 Million - $3 Million
26,797 Added 10.83%
274,334 $26.5 Billion
Q2 2022

Aug 14, 2024

BUY
$102.07 - $123.37 $883,007 - $1.07 Million
8,651 Added 3.62%
247,537 $26.9 Billion
Q1 2022

Aug 14, 2024

SELL
$114.02 - $139.04 $13 Million - $15.8 Million
-113,941 Reduced 32.29%
238,886 $28.3 Billion
Q4 2021

Aug 30, 2024

BUY
$115.53 - $141.46 $5.76 Million - $7.05 Million
49,820 Added 26.53%
237,573 $33.4 Billion
Q3 2021

Aug 30, 2024

BUY
$116.66 - $129.06 $924,880 - $1.02 Million
7,928 Added 4.41%
187,753 $22.2 Billion
Q2 2021

Aug 30, 2024

SELL
$105.79 - $124.53 $18.3 Million - $21.5 Million
-173,002 Reduced 49.03%
179,825 $20.8 Billion
Q1 2021

Aug 30, 2024

BUY
$108.84 - $128.23 $9.31 Million - $11 Million
85,506 Added 107.97%
164,700 $19.7 Billion
Q4 2020

Aug 30, 2024

BUY
$105.0 - $114.42 $2.93 Million - $3.19 Million
27,894 Added 54.37%
79,194 $8.67 Billion
Q3 2020

Aug 30, 2024

BUY
$91.64 - $111.29 $46,278 - $56,201
505 Added 0.99%
51,300 $5.58 Billion
Q2 2020

Aug 30, 2024

SELL
$76.57 - $98.0 $90,735 - $116,130
-1,185 Reduced 2.28%
50,795 $4.64 Billion
Q1 2020

Aug 30, 2024

SELL
$62.82 - $91.86 $313,723 - $458,748
-4,994 Reduced 8.77%
51,980 $4.1 Billion
Q4 2019

Aug 30, 2024

SELL
$78.51 - $87.4 $124,752 - $138,878
-1,589 Reduced 2.71%
56,974 $4.95 Billion
Q3 2019

Aug 30, 2024

SELL
$81.84 - $88.74 $890,910 - $966,023
-10,886 Reduced 15.67%
58,563 $4.9 Billion
Q2 2019

Aug 30, 2024

SELL
$72.88 - $85.0 $373,145 - $435,200
-5,120 Reduced 6.87%
69,449 $5.84 Billion
Q1 2019

Aug 30, 2024

BUY
$66.22 - $80.06 $101,449 - $122,651
1,532 Added 2.1%
74,569 $5.96 Billion
Q4 2018

Aug 30, 2024

SELL
$65.56 - $74.27 $18.3 Million - $20.8 Million
-279,790 Reduced 79.3%
73,037 $5.28 Billion
Q3 2018

Aug 30, 2024

SELL
$60.81 - $73.36 $142,173 - $171,515
-2,338 Reduced 3.15%
71,834 $5.27 Billion
Q2 2018

Aug 30, 2024

SELL
$57.57 - $63.54 $109,325 - $120,662
-1,899 Reduced 2.5%
74,172 $4.52 Billion
Q1 2018

Aug 30, 2024

SELL
$56.27 - $63.62 $349,886 - $395,589
-6,218 Reduced 7.56%
76,071 $4.56 Billion
Q4 2017

Aug 30, 2024

SELL
$53.68 - $57.47 $137,850 - $147,582
-2,568 Reduced 3.03%
82,289 $4.7 Billion
Q3 2017

Aug 30, 2024

BUY
$48.06 - $53.64 $14,369 - $16,038
299 Added 0.35%
84,857 $4.53 Billion
Q2 2017

Aug 30, 2024

BUY
N/A
10,634 Added 14.39%
84,558 $4.11 Billion
Q1 2017

Aug 30, 2024

SELL
N/A
-278,903
73,924 $3.28 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $224B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.